AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391,669 | -10.9% | 15,825 | +1.9% | 0.00% | -25.0% |
| Q2 2023 | $439,781 | +33.6% | 15,529 | +8.4% | 0.00% | +33.3% |
| Q1 2023 | $329,114 | -15.8% | 14,328 | +2.9% | 0.00% | -25.0% |
| Q4 2022 | $390,902 | +3.1% | 13,921 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $379,000 | +28.5% | 13,400 | +0.6% | 0.00% | +33.3% |
| Q2 2022 | $295,000 | -23.4% | 13,326 | +0.9% | 0.00% | 0.0% |
| Q1 2022 | $385,000 | -17.9% | 13,212 | -7.5% | 0.00% | -25.0% |
| Q4 2021 | $469,000 | -32.7% | 14,280 | -5.4% | 0.00% | -33.3% |
| Q3 2021 | $697,000 | -25.7% | 15,095 | -11.4% | 0.01% | -25.0% |
| Q2 2021 | $938,000 | +0.1% | 17,028 | -6.2% | 0.01% | 0.0% |
| Q1 2021 | $937,000 | +19.8% | 18,145 | +0.6% | 0.01% | +14.3% |
| Q4 2020 | $782,000 | +19.4% | 18,038 | -3.6% | 0.01% | 0.0% |
| Q3 2020 | $655,000 | -12.0% | 18,708 | +34.4% | 0.01% | -30.0% |
| Q2 2020 | $744,000 | +48.2% | 13,918 | -1.7% | 0.01% | +11.1% |
| Q1 2020 | $502,000 | – | 14,157 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |